Article

Circulating proteins to predict adverse COVID-19 outcomes

2021-10-05

Abstract excerpt

Predicting COVID-19 severity is difficult, and the biological pathways involved are not fully understood. To approach this problem, we measured 4,701 circulating human protein abundances in two independent cohorts totaling 986 individuals. We then trained prediction models including protein abundances and clinical risk factors to predict adverse COVID-19 outcomes in 417 subjects and tested these models in a separa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ea83d3a1-515c-5876-bbde-23318ca9e914
DOI: 10.1101/2021.10.04.21264015

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating proteins to predict adverse COVID-19 outcomesDOI 10.1101/2021.10.04.21264015Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read

Inflammation Patterns in Omicron Variant-Linked COVID-19: Assessing Biomarkers for Predicting Disease SeveritySemantic proximity Read

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read

Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19Semantic proximity Read

Predicting COVID-19 Patients Outcome Trajectories Using Proteomics and Clinical Biosignatures: A Comprehensive Machine Learning and Bioinformatics ApproachSemantic proximity Read

Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical StudiesSemantic proximity Read

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients.Semantic proximity Read

Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19Semantic proximity Read

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read

High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversionSemantic proximity Read